Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Solanbridge Group Inc finalizing acquisition of Colorado Medical Marijuana Product Producer


Monday, 5 May 2014 06:11am EDT 

Solanbridge Group Inc:Final negotiations to acquire Colorado health product producer.Negotiations for acquisition are in their final stages. 

Company Quote

0.0022
-2.0E-4 -8.33%
25 Aug 2014